Asia Pacific Cardiovascular Devices Market Size & Outlook

The cardiovascular devices in Asia Pacific is expected to reach a projected revenue of US$ 17,268.7 million by 2030. A compound annual growth rate of 8.9% is expected of Asia Pacific cardiovascular devices from 2025 to 2030.
Revenue, 2024 (US$M)
$10,454.5
Forecast, 2030 (US$M)
$17,268.7
CAGR, 2025 - 2030
8.9%
Report Coverage
Asia Pacific

Asia Pacific cardiovascular devices, 2018-2030 (US$M)

Asia
Unlock Premium

Asia Pacific cardiovascular devices highlights

  • The Asia Pacific cardiovascular devices generated a revenue of USD 10,454.5 million in 2024.
  • The market is expected to grow at a CAGR of 8.9% from 2025 to 2030.
  • In terms of segment, surgical devices was the largest revenue generating products in 2024.
  • Diagnostic & Monitoring Devices is the most lucrative products segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 10,454.5 million
Market revenue in 2030USD 17,268.7 million
Growth rate8.9% (CAGR from 2025 to 2030)
Largest segmentSurgical devices
Fastest growing segmentDiagnostic & Monitoring Devices
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostic & Monitoring Devices, Surgical Devices
Key market players worldwideAbbott Laboratories, GE HealthCare Technologies Inc Common Stock, Edwards Lifesciences Corp, W.L. Gore & Associates, Siemens Healthineers AG ADR, BIOTRONIK, Canon Inc, B. Braun, LivaNova PLC, Cardinal Health Inc, Medtronic PLC, Boston Scientific Corp

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 19.5% of the global cardiovascular devices in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 17,268.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cardiovascular Devices Scope

Cardiovascular Devices Companies

Name Profile # Employees HQ Website

Asia Pacific cardiovascular devices outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiovascular devices will help companies and investors design strategic landscapes.


Surgical devices was the largest segment with a revenue share of 69.67% in 2024. Horizon Databook has segmented the Asia Pacific cardiovascular devices based on diagnostic & monitoring devices, surgical devices covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific cardiovascular devices databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific cardiovascular devices databook

  • Our clientele includes a mix of cardiovascular devices companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cardiovascular devices, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cardiovascular devices from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific cardiovascular devices market size, by country, 2018-2030 (US$M)

Asia Pacific Cardiovascular Devices Share, 2024 & 2030 (US$M)

Asia Pacific cardiovascular devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more